Kei Kishimoto

Company: Selecta Biosciences Inc.

Job title: Chief Scientific Officer

Seminars:

Strategizing Methods to Mitigate Against Neutralizing Antibodies in AAV Gene Therapy 2:30 pm

• Leveraging bacterial enzymes to circumvent neutralizing antibodies • Exploring novel approaches to dosing patients with pre-existing immunity • Optimizing neutralizing antibody assays to improve standardizationRead more

day: Day One